Americas Sterility Testing Market Overview
Americas Sterility Testing Market Size was valued at USD 0.46 Billion in 2023. The Global Americas Sterility Testing industry is projected to grow from USD 0.51 Billion in 2024 to USD 1.11 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.31% during the forecast period (2024 - 2032). Sterility testing is one of the important aspect in the healthcare sector. It ensures the purity and safety of a product or a substance. Sterilization of the product and devices ensures the safety of the products.
The major driving factor for the growth of the market are increasing manufactures of the medical devices & products, increasing prevalence of many infectious diseases, and increasing in the R&D activities. According to the Centers for Disease Control and Prevention, in 2012, about half of all adults i.e. 117 million American had one or more chronic health problem.
Increasing number of diseases has intensified the research activities, which has significantly driven the market. Furthermore, technological advances, growth of pharmaceutical industries, increasing support provided by the government and increasing R&D investment have fuelled the market growth in this region. However, time consuming approval process and strict regulatory guidelines are the key factors responsible for slow the market growth, which is expected to do so over the given period.
Intended Audience
- Product manufacturers of sterility product
- Sterility testing product distributors
- Government and private research companies
- Research and development (R&D) companies
- Hospitals and laboratories
- Medical research laboratories
- Academic medical institutes and universities
Americas Sterility Testing Market Segment Insights
Americas Sterility Testing Market Product Insights
On basis of type of product, the market is segmented into instrument, reagent & services, kits, and others.
Americas Sterility Testing Market Type Of Tests Insights
On the basis of type of tests, the market is segmented into membrane filtration sterility testing, direct incubation sterility testing, direct transfer, and others.
Americas Sterility Testing Market Application Insights
On the basis of application, the market is segmented into pharmaceutical & biological manufacturing, medical devices manufacturing, and others.
Americas Sterility Testing Market End User Insights
On the bais of end user, they are segmented into pharmaceutical, hospital and laboratories.
Americas Sterility Testing Market Regional Insights
On the regional basis, the Americas is segmented into North America and South America. North America holds a major share of the market owing to increasing number of approval of new drugs, increasing demand for the better quality products and increasing number of healthcare organizations like hospital, private research institute has led to increase in the market in North America. America sterility testing market is segmented into the US and Canada. The US is the major contributor to the market in this region. South America shows a steady growth in the market.
Americas Sterility Testing Market Key Players
Key Players
Some of the major player in the market are:
- Charles River Laboratories International, Inc. (US)
- Avance Biosciences (US)
- Boston Scientific Corporation (US)
- Paragon Bioservices, Inc (US)
- Thermo Fisher Scientific, Inc. (U.S.)
- Avista Pharma Solutions (US)
- DYNALABS LLC. (US)
- Merck KGaA (Germany)
Report Attribute/Metric
|
Details
|
Market Size
|
USD 1.11 Billion by 2032
|
CAGR
|
  10.31% (2024-2032)
|
Base Year
|
  2021
|
Forecast Period
|
  2024-2032
|
Historical Data
|
  2020
|
Forecast Units
|
 Value (USD Million)
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
Segments Covered
|
Types, end user, Region
|
Geographies Covered
|
North America and South America
|
Key Vendors
|
Charles River Laboratories International, Inc. (US), Avance Biosciences (US), Boston Scientific Corporation (US), Paragon Bioservices, Inc (US), Thermo Fisher Scientific, Inc. (U.S.), Avista Pharma Solutions (US), DYNALABS LLC. (US), and Merck KGaA (Germany)
|
Americas Sterility Testing Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report